A phase 2, randomized, double-blind, placebo-controlled parallel group study of VHB937 in Amyotrophic Lateral Sclerosis (ALS) over 40 weeks followed by an Open-label Extension (ASTRALS)

Rowe, Dominic (Primary Chief Investigator)
Delcourt, Candice (Associate Investigator)
Kalband, Balaji (Associate Investigator)
Gan, Richard (Research Coordinator)
Bayeh, Paula (Research Coordinator)

Macquarie Medical School

Project: Research

Short title	CVHB937B12201
Acronym	ASTRALS
Status	Active
Effective start/end date	16/04/25 → 30/10/29